Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,699.38
(
1.01%
)
US TECH 100
23,992.28
(
1.03%
)
Dow Jones
46,946.41
(
0.83%
)
Brent Oil
100.08
(
1.81%
)
Bitcoin
75,370.01
(
0.70%
)
News Focus
News Focus
Post# of 257250
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 155773

Monday, 06/30/2014 6:53:36 PM

Monday, June 30, 2014 6:53:36 PM

Post# of 257250

AGN—[Peak annual Semprana sales of $500M is] probably higher than I would have guessed given that insurers will likely be cautious covering this drug.

Given the three CRLs issued for this drug (the third one announced today), we may never find out what the true market potential is.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now